diazoxide has been researched along with Pancreatitis in 5 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Pancreatitis: INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diazoxide was given orally to nine hypertensive patients with renal failure and its effect on blood pressure and on glucose metabolism was studied." | 5.25 | Oral diazoxide contraindicated in severe hypertension with renal failure. ( Belpaire, FM; De Broe, ME; Mussche, MM; Ringoir, SM; Vermeulen, A, 1975) |
| " Less convincing, but suggestive evidence exists for: 1-asparaginase, iatrogenic hypercalcemia, chlorthalidine, corticosteroids, ethacrynic acid, phenformin, and procainamide." | 4.76 | Drug-induced pancreatitis: a critical review. ( Kern, F; Mallory, A, 1980) |
| "Diazoxide was given orally to nine hypertensive patients with renal failure and its effect on blood pressure and on glucose metabolism was studied." | 1.25 | Oral diazoxide contraindicated in severe hypertension with renal failure. ( Belpaire, FM; De Broe, ME; Mussche, MM; Ringoir, SM; Vermeulen, A, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mallory, A | 1 |
| Kern, F | 1 |
| MartÃn, F | 1 |
| Soria, B | 1 |
| Mussche, MM | 1 |
| De Broe, ME | 1 |
| Belpaire, FM | 1 |
| Vermeulen, A | 1 |
| Ringoir, SM | 1 |
| De Broe, M | 1 |
| Mussche, M | 1 |
| Bosteels, V | 1 |
| Stefanini, P | 1 |
| Carboni, M | 1 |
| Patrassi, N | 1 |
| Basoli, A | 1 |
1 review available for diazoxide and Pancreatitis
| Article | Year |
|---|---|
Drug-induced pancreatitis: a critical review.
Topics: Acetaminophen; Adrenal Cortex Hormones; Amphetamines; Asparaginase; Azathioprine; Chlorthalidone; Ch | 1980 |
4 other studies available for diazoxide and Pancreatitis
| Article | Year |
|---|---|
Glucose-induced [Ca2+]i oscillations in single human pancreatic islets.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biological Transport; Calcium; Cells, Cultured; Diaz | 1996 |
Oral diazoxide contraindicated in severe hypertension with renal failure.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Blood Glucose; Diabetic Ketoacidosis; Diazoxide; F | 1975 |
Oral diazoxide for malignant hypertension.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Diabetic Ketoacidosis; Diazoxide; Female; Humans; | 1972 |
Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases.
Topics: Adenoma, Islet Cell; Adult; Age Factors; Angiography; Child, Preschool; Diazoxide; Female; Glucose T | 1974 |